Where it comes from
Alpha-MSH is a 13-amino-acid hormone the body makes naturally. KPV is its final three amino acids, positions 11 to 13, made on their own. That is why PubChem also lists it as alpha-MSH (11-13).
It has been studied in cell and animal research. It has not been through the clinical trials needed to become a licensed medicine anywhere.
Small, so easy to check
At three amino acids, KPV is one of the smallest peptides sold for research, which makes its identity simple to confirm:
Regulatory status
KPV is not an approved medicine in the UK, the EU or the US. In the UK, a product presented or sold for use in people is treated as a medicine, which needs a licence from the MHRA.
The FDA placed KPV in category 2 of its interim compounding policies, for bulk substances that may present significant safety risks. The nomination has since been withdrawn: the FDA now lists KPV under "nominated but withdrawn", still noting it had found no human exposure data for any route.
Educational information only. Nothing here is medical advice, dosing guidance or a recommendation to use any substance. Research peptides are not approved medicines and are not for human or animal consumption. Speak to a qualified professional and follow the law where you are.
